Stevanato Group Spa

Stevanato Group Spa

STVN - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$5.29B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Stevanato Group SpaStevanato Group Spa360.32%9%50.3
$3.27

Current Fair Value

83.5% downside

Overvalued by 83.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$5.29 Billion
Enterprise Value$5.75 Billion
Annual dividend$0.06
Dividend yield0.32%
Earnings per Share$0.49
Beta0.78
Outstanding Shares273,000,000

Return

Return on Equity8.66%ROE
Return on Assets5.13%
Return on Invested Capital9.76%

Valuation & Multiples

P/E Ratio36.02P/E Ratio
PEG-159.65PEG
Price to Sales4.95Price to Sales
Price to Book Ratio3.96Price to Book Ratio
Enterprise Value to Revenue4.7
Enterprise Value to EBIT28.85
Enterprise Value to Net Income42
Total Debt to Enterprise0.09
Debt to Equity0.35Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 4, 2026
EPS Estimate
$0.14
Consensus analyst estimate
Revenue Estimate
$340.58 M
Consensus analyst estimate

Next Earnings Call

Expected Date
November 3, 2026
EPS Estimate
$0.18
Consensus analyst estimate
Revenue Estimate
$363.27 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %1.08%▼ 15.32%
Total Invested$61.57M▼ 92.39%
Investors Holding26▼ 101.00%

About Stevanato Group Spa

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end por...

Stevanato Group Spa Insider Information FAQ

Stockcircle tracks 6 top investors with a current 13F position in Stevanato Group Spa. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 3 top investors increased or opened positions and 3 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 8 open-market insider sales for Stevanato Group Spa in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.